Oliver Sartor

Tulane University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Scott Tagawa

Weill Cornell Medicine

UNITED STATES

View details

David Einstein

Beth Israel Deaconess Medical Center

UNITED STATES

View details

Bertrand TOMBAL

Université catholique de Louvain

BELGIUM

View details

Silke Gillessen

The University of Manchester

UNITED KINGDOM

View details

Maha Hussain

UNITED STATES

View details

Jason Brown

Assistant Professor

University Hospital

UNITED STATES

View details

Benjamin Leiby

Professor

Thomas Jefferson University

UNITED STATES

View details

Christopher J. Sweeney

University of Adelaide

AUSTRALIA

View details

Russell Z. Szmulewitz

University of Chicago

UNITED STATES

View details

Daniel Sentana Lledo

Harvard University

UNITED STATES

View details

Steven Balk

Harvard University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oliver Sartor

Research Interests

Explore related searches

Contact this professor

Articles (14)

Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA

Prostate-specific Membrane Antigen–targeted Isotope Therapy: Inherent Challenges Owing to Heterogeneity and Clonal Evolution

Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies

Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer

Circulating Tumor DNA Biomarkers for Response Assessment in Prostate Cancer

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer

Localized Prostate Cancer — Then and Now

Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer

Radium-223 and bone metastatic disease: still more to learn

Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?

Immune mechanisms behind prostate cancer in men of African ancestry: A review

Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)

Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC

Collaborators (11)

Scott Tagawa

David Einstein

Bertrand TOMBAL

Silke Gillessen

Maha Hussain

Jason Brown

Benjamin Leiby

Christopher J. Sweeney

Russell Z. Szmulewitz

Daniel Sentana Lledo

Steven Balk

Make your next move.